Author Index

Search or browse for an author across our entire electronic archive

Search results for: K
Results 131 - 140 of 1824 shown below

  • Kalk, E

    J C Steele, E E Torr, K L Noakes, E Kalk, P A Moss, G M Reynolds, S G Hubscher, M van Lohuizen, D H Adams and L S Young

    The polycomb group proteins, BMI-1 and EZH2, are tumour-associated antigens

    advance online publication, 2006-10-03 00:00:00.000;

    doi:10.1038/sj.bjc.6603369

  • Kalland, K H

    I B Engelsen, M Mannelqvist, I M Stefansson, S L Carter, R Beroukhim, A M Øyan, A P Otte, K H Kalland, L A Akslen and H B Salvesen

    Low BMI-1 expression is associated with an activated BMI-1-driven signature, vascular invasion, and hormone receptor loss in endometrial carcinoma

    advance online publication, 2008-05-13 00:00:00.000;

    doi:10.1038/sj.bjc.6604360

  • Kallenborn, A

    H Engel, C Kleespies, J Friedrich, M Breidenbach, A Kallenborn, T Schöndorf, H Kolhagen and P Mallmann

    Detection of circulating tumour cells in patients with breast or ovarian cancer by molecular cytogenetics

    doi:10.1038/sj.bjc.6690825

  • Kallifatidis, G

    B M Beckermann, G Kallifatidis, A Groth, D Frommhold, A Apel, J Mattern, A V Salnikov, G Moldenhauer, W Wagner, A Diehlmann, R Saffrich, M Schubert, A D Ho, N Giese, M W Büchler, H Friess, P Büchler and I Herr

    VEGF expression by mesenchymal stem cells contributes to angiogenesis in pancreatic carcinoma

    advance online publication, 2008-07-29 00:00:00.000;

    doi:10.1038/sj.bjc.6604508

  • Kallimanis, G

    A Apessos, M Mihalatos, I Danielidis, G Kallimanis, N J Agnantis, J K Triantafillidis, G Fountzilas, P A Kosmidis, E Razis, V A Georgoulias and G Nasioulas

    hMSH2 is the most commonly mutated MMR gene in a cohort of Greek HNPCC patients

    advance online publication, 2005-01-11 00:00:00.000;

    doi:10.1038/sj.bjc.6602260

  • Kallincos, N C

    C J Xian, R Couper, G S Howarth, L C Read and N C Kallincos

    Increased expression of HGF and c-met in rat small intestine during recovery from methotrexate-induced mucositis

    doi:10.1054/bjoc.1999.1023

  • Kallio, J P

    J P Kallio, P Hirvikoski, H Helin, P Kellokumpu-Lehtinen, T Luukkaala, T L J Tammela and P M Martikainen

    Membranous location of EGFR immunostaining is associated with good prognosis in renal cell carcinoma

    doi:10.1038/sj.bjc.6601241

  • Kallioniemi, A

    J Pärssinen, T Kuukasjärvi, R Karhu and A Kallioniemi

    High-level amplification at 17q23 leads to coordinated overexpression of multiple adjacent genes in breast cancer

    advance online publication, 2007-03-13 00:00:00.000;

    doi:10.1038/sj.bjc.6603692

  • F Forozan, R Veldman, C A Ammerman, N Z Parsa, A Kallioniemi, O-P Kallioniemi and S P Ethier

    Molecular cytogenetic analysis of 11 new breast cancer cell lines

    doi:10.1038/sj.bjc.6695007

  • Kallioniemi, O P

    N Mononen, T Ikonen, K Syrjäkoski, M Matikainen, J Schleutker, T L J Tammela, P A Koivisto and O P Kallioniemi

    A missense substitution A49T in the steroid 5-alpha-reductase gene (SRD5A2) is not associated with prostate cancer in Finland

    doi:10.1054/bjoc.2001.1789

  • Kallioniemi, O-P

    A C Antoniou, A P Cunningham, J Peto, D G Evans, F Lalloo, S A Narod, H A Risch, J E Eyfjord, J L Hopper, M C Southey, H Olsson, O Johannsson, A Borg, B Passini, P Radice, S Manoukian, D M Eccles, N Tang, E Olah, H Anton-Culver, E Warner, J Lubinski, J Gronwald, B Gorski, L Tryggvadottir, K Syrjakoski, O-P Kallioniemi, H Eerola, H Nevanlinna, P D P Pharoah and D F Easton

    The BOADICEA model of genetic susceptibility to breast and ovarian cancers: updates and extensions

    advance online publication, 2008-03-18 00:00:00.000;

    doi:10.1038/sj.bjc.6604305

  • A C Antoniou, A P Cunningham, J Peto, D G Evans, F Lalloo, S A Narod, H A Risch, J E Eyfjord, J L Hopper, M C Southey, H Olsson, O Johannsson, A Borg, B Pasini, P Radice, S Manoukian, D M Eccles, N Tang, E Olah, H Anton-Culver, E Warner, J Lubinski, J Gronwald, B Gorski, L Tryggvadottir, K Syrjakoski, O-P Kallioniemi, H Eerola, H Nevanlinna, P D P Pharoah and D F Easton

    The BOADICEA model of genetic susceptibility to breast and ovarian cancers: updates and extensions

    doi:10.1038/sj.bjc.6604411

  • K Rapakko, M Allinen, K Syrjäkoski, P Vahteristo, P Huusko, K Vähäkangas, H Eerola, T Kainu, O-P Kallioniemi, H Nevanlinna and R Winqvist

    Germline TP53 alterations in Finnish breast cancer families are rare and occur at conserved mutation-prone sites

    doi:10.1054/bjoc.2000.1530

  • F Forozan, R Veldman, C A Ammerman, N Z Parsa, A Kallioniemi, O-P Kallioniemi and S P Ethier

    Molecular cytogenetic analysis of 11 new breast cancer cell lines

    doi:10.1038/sj.bjc.6695007